Unicycive Therapeutics, Inc. (UNCY) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-15

Unicycive Therapeutics, Inc. (UNCY) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 5 Form 8-K material event filings were reported by UNCY in the last 90 days. 1 Form 144 notices of proposed sale were filed for UNCY stock. InsiderAlpha tracks every UNCY SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Unicycive Therapeutics, Inc. (UNCY)

SEC CIK	0001766140

90-Day SEC Filing Activity

Form 4 filings (90d)	12
Form 8-K filings (90d)	5
Form 144 notices (90d)	1
Latest Form 4 filing	2026-06-15

Recent UNCY Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-08-25	Aggarwal Gaurav	Director	J — Other acquisition / disposition	652.9K	—	—	SEC
2024-10-09	Aggarwal Gaurav	Director	J — Other acquisition / disposition	5.50M	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Unicycive Therapeutics, Inc. (UNCY). Updated in real time as new filings are submitted to the SEC.

Most-Active UNCY Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Kenkare-Mitra Sara	4	—
Laumas Sandeep	4	—
Townsend John	2	—
Jermasek Douglas	2	—
Gupta Pramod	2	—

Recent UNCY Form 8-K Material Events

2026-07-02 — Item 8.01 [SEC]
2026-06-30 — Other · neutral [SEC]
Trading halt (T1) for UNCY. UNCY
2026-06-22 — Item 5.07 [SEC]
2026-06-05 — Item 1.01, 9.01 [SEC]
2026-05-12 — Item 2.02, 9.01 [SEC]

Recent UNCY Form 144 Notices of Proposed Sale

2026-07-01 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-06-15 — Gupta Shalabh K. (CEO)
2026-06-15 — Kenkare-Mitra Sara (Director)
2026-06-15 — Laumas Sandeep (Director)
2026-06-15 — Gupta Pramod (EVP, Pharmaceuticals and BD)
2026-06-15 — Townsend John (CFO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in UNCY insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

UNCY Insider Trading — FAQ

What is the latest insider trade for UNCY?: Unicycive Therapeutics, Inc. (UNCY) had 12 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying UNCY stock?: 0 insider purchases of UNCY were filed in the last 90 days.
How many insiders are selling UNCY stock?: 0 insider sales of UNCY were filed in the last 90 days.
Where can I see UNCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every UNCY SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live UNCY dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.